ESR1 and neoplasm: Also, as observed in xenograft assays, tumor growth was attenuated in the absence of DSCAM1. Further, it was found that tamoxifen resistance is associated with higher DSCAM-AS1 expression, along with higher ERα, likely due to the continued absence of estrogen that leads to a compensatory signaling pathway.